Search by Drug Name or NDC
NDC 70069-0752-25 Bupivacaine hydrochloride 2.5 mg/mL Details
Bupivacaine hydrochloride 2.5 mg/mL
Bupivacaine hydrochloride is a INFILTRATION; PERINEURAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Somerset Therapeutics, LLC. The primary component is BUPIVACAINE HYDROCHLORIDE.
Product Information
| NDC | 70069-0752 |
|---|---|
| Product ID | 70069-752_86b0d5d5-6a92-419f-9060-25598fe19aae |
| Associated GPIs | |
| GCN Sequence Number | 003358 |
| GCN Sequence Number Description | bupivacaine HCl VIAL 2.5 MG/ML INJECTION |
| HIC3 | H0A |
| HIC3 Description | LOCAL ANESTHETICS |
| GCN | 11700 |
| HICL Sequence Number | 001470 |
| HICL Sequence Number Description | BUPIVACAINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Bupivacaine hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Bupivacaine hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INFILTRATION; PERINEURAL |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | BUPIVACAINE HYDROCHLORIDE |
| Labeler Name | Somerset Therapeutics, LLC |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA217792 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70069-0752-25 (70069075225)
| NDC Package Code | 70069-752-25 |
|---|---|
| Billing NDC | 70069075225 |
| Package | 25 VIAL in 1 CARTON (70069-752-25) / 50 mL in 1 VIAL |
| Marketing Start Date | 2023-11-27 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |